According to the U.S. Food and Drug Administration (FDA), data from an ongoing 10-year study conducted by Kaiser Permanente reveals that using Actos for more than one year may significantly increase the risk of developing bladder cancer.
(PRWEB) February 12, 2013
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit alleging that Actos caused bladder cancer in a Pennsylvania man. The suit was filed on February 5th in the U.S. District Court for the Western District of Louisiana, Lafayette Division (Case No. 6:13-cv-0267). This is just one of many cases pending in the Actos multidistrict litigation entitled In Re: Actos (Pioglitazone) Products Liability Litigation (MDL No. 6:11-md-2299). Jerrold S. Parker, founding partner of Parker Waichman LLP, serves on the Plaintiff’s Steering Committee in the litigation. Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceutical Company Limited and Eli Lilly and Company have been named as Defendants.
According to the Complaint, the Plaintiff started taking Actos in August 2009. Thereafter, he developed bladder cancer in March 2011, allegedly due to using the diabetes drug. The lawsuit alleges that the Defendants knew Actos could cause bladder cancer but did not warn the Plaintiff or the public. Instead, the suit alleges, they made misrepresentations and omissions in order to conceal the risks of taking Actos. The lawsuit alleges that there are several safer alternatives for treating Type 2 diabetes, and that the Plaintiff would not have taken Actos if he were fully informed of the risks. The Plaintiff is suing for severe mental and physical pain and suffering, permanent injuries, emotional distress and economic loss due to medical expenses and living-related expenses due to a new lifestyle.
According to the U.S. Food and Drug Administration (FDA), data from an ongoing 10-year study conducted by Kaiser Permanente reveals that using Actos for more than one year may significantly increase the risk of developing bladder cancer. In 2011, the agency updated the warning label on the medication to include this risk. Last May, the British Medical Journal (BMJ) published a study showing that patients who took Actos for two years were twice as likely to get bladder cancer. Yet, another study, published last summer in the Canadian Medical Association Journal, found that use of Actos was linked to a 22 percent increased risk of developing bladder cancer.
Parker Waichman LLP continues to offer free legal consultations to victims of Actos injuries, including bladder cancer, heart problems, and eye injuries. If you or a loved one were diagnosed with bladder cancer after taking Actos, please contact their office by visiting yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).